{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:28:04Z","timestamp":1788560884479,"version":"build-2803163510"},"reference-count":57,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNR"],"published-print":{"date-parts":[[2019,5,13]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Endothelial Progenitor Cells (EPCs) are important players in neovascularization, mobilized through signalling by Angiogenic Growth Factors (AGFs) such as Vascular Endothelial Growth Factor (VEGF) and fibroblast growth factor (FGF). In vitro, inflammatory parameters impair the function and influence of EPCs on AGFs. However, this connection is not clear in vivo. To understand the mechanisms of augmented arteriogenesis and angiogenesis in acute ischemic stroke (AIS) patients, we investigated whether circulating stem cells (CD133+), early endothelial progenitor cells (CD133+\/VEGFR2+), and endothelial cells (ECs; CD34\u00af\/CD133\u00af\/VEGFR2+) were increasingly mobilized during AIS, and whether there were correlations between EPC levels, growth factor levels and inflammatory parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Data on demographics, classical vascular risk factors, neurological deficit information (assessed using the National Institutes of Health Stroke Scale), and treatment were collected from 43 consecutive AIS patients (group I). Risk factor control patients (group II) included 22 nonstroke subjects matched by age, gender, and traditional vascular risk factors. EPCs were measured by flow cytometry and the populations of circulating stem cells (CD133+), early EPCs (CD133+\/VEGFR2+), and ECs (CD34\u00af\/CD133\u00af\/VEGFR2+) were analysed. Correlations between EPC levels and VEGF and FGF vascular growth factor levels as well as the influence of inflammatory parameters on EPCs and AGFs were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Patient ages ranged from 54 to 92 years (mean age 75.2 \u00b1 11.3 years). The number of circulating CD34\u00af\/CD133\u00af\/VEGF-R2+ cells was significantly higher in AIS patients than in control patients (p &lt; 0.05). VEGF plasma levels were also significantly higher in AIS patients compared to control patients on day 7 (p &lt; 0.05). FGF plasma levels in patients with AIS were significantly higher than those in the control group on day 3 (p &lt; 0.05). There were no correlations between increased VEGF and FGF levels and the number of CD133+, CD133+\/VEGFR2+, or CD34\u00af\/CD133\u00af\/VEGFR2+ cells. Leukocyte levels, FGF plasma levels, and the number of early EPCs were negatively correlated on day 3. High sensitivity C-reactive protein levels and the number of CD133+ and CD133+\/VEGFR2+ cells were negatively correlated on day 7. In addition, there was a negative correlation between fibrinogen levels and FGF plasma levels as well as the number of early EPCs (CD133+\/VEGFR2+).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>AIS patients exhibited increased numbers of early EPCs (CD133+\/VEGFR2+) and AGF (VEGF and FGF) levels. A negative correlation between inflammatory parameters and AGFs and EPCs indicated the unfavourable influence of inflammatory factors on EPC differentiation and survival. Moreover, these correlations represented an important mechanism linking inflammation to vascular disease.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1567202616666190129164906","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T11:06:29Z","timestamp":1549019189000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+\/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients"],"prefix":"10.2174","volume":"16","author":[{"given":"Monika","family":"Golab-Janowska","sequence":"first","affiliation":[{"name":"Department of Neurology, Pomeranian Medical University, Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Paczkowska","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University, Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boguslaw","family":"Machalinski","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Pomeranian Medical University, Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Kotlega","sequence":"additional","affiliation":[{"name":"Department of Neurology, Pomeranian Medical University, Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Meller","sequence":"additional","affiliation":[{"name":"Department of Neurology, Pomeranian Medical University, Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Safranow","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Wankowicz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Pomeranian Medical University, Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Nowacki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Pomeranian Medical University, Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"854597","DOI":"10.1155\/2013\/854597","volume":"2013","author":"Faralli A.","year":"2013","unstructured":"Faralli A, Bigoni M, Mauro A. Neural Plast, Noninvasive strategies to promote functional recovery after stroke.,, 2013, 2013,, 854597-,","journal-title":"Neural Plast"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.55782\/ane-2013-1922","volume":"73","author":"Ortega F.J.","year":"2013","unstructured":"Ortega FJ, Jolkkonen J. Acta Neurobiol Exp, Restorative therapies to enhance sensorimotor recovery following cerebral ischemia.,, 2013, 73,, 66-78,","journal-title":"Acta Neurobiol Exp"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.4103\/1673-5374.139457","volume":"9","author":"Peplow P.V.","year":"2014","unstructured":"Peplow PV. Neural Regen Res, Growth factor- and cytokine-stimulated endothelial progenitor cells in post-ischemic cerebral neovascularization.,, 2014, 9,, 1425-1429,","journal-title":"Neural Regen Res"},{"key":"ref=4","first-page":"888","volume":"7","author":"Shah P.P.","year":"2013","unstructured":"Shah PP, Szaflarski JP, Allendorfer J, Hamilton RH. Front Hum Neurosci, Induction of neuroplasticity and recovery in post-stroke aphasia by non-invasive brain stimulation.,, 2013, 7,, 888-,","journal-title":"Front Hum Neurosci"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","volume":"386","author":"Risau W.","year":"1997","unstructured":"Risau W. Nature, Mechanisms of angiogenesis.,, 1997, 386,, 671-674,","journal-title":"Nature"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10157-006-0448-1","volume":"11","author":"Eguchi M.","year":"2007","unstructured":"Eguchi M, Masuda H, Asahara T. Clin Exp Nephrol, Endothelial progenitor cells for postnatal vasculogenesis.,, 2007, 11,, 18-25,","journal-title":"Clin Exp Nephrol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1050-1738(01)00152-9","volume":"12","author":"Luttun A.","year":"2002","unstructured":"Luttun A, Carmeliet G, Carmeliet P. Trends Cardiovasc Med, Vascular progenitors: From biology to treatment.,, 2002, 12,, 88-96,","journal-title":"Trends Cardiovasc Med"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrc925","volume":"2","author":"Rafii S.","year":"2002","unstructured":"Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Nat Rev Cancer, Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy?,, 2002, 2,, 826-835,","journal-title":"Nat Rev Cancer"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/152581602753658385","volume":"11","author":"Asahara T.","year":"2002","unstructured":"Asahara T, Isner JM. J Hematother Stem Cell Res, Endothelial progenitor cells for vascular regeneration.,, 2002, 11,, 171-178,","journal-title":"J Hematother Stem Cell Res"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.0000058702.69484.A0","volume":"107","author":"Rehman J.","year":"2003","unstructured":"Rehman J, Li J, Orschell CM, March KL. Circulation, Peripheral blood \u201cendothelial progenitor cells\u201d are derived from monocyte\/macrophages and secrete angiogenic growth factors.,, 2003, 107,, 1164-1169,","journal-title":"Circulation"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","volume":"6","author":"Carmeliet P.","year":"2000","unstructured":"Carmeliet P. Nat Med, Mechanisms of angiogenesis and arteriogenesis.,, 2000, 6,, 389-395,","journal-title":"Nat Med"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"Yancopoulos G.D.","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Nature, Vascular-specific growth factors and blood vessel formation.,, 2000, 407,, 242-248,","journal-title":"Nature"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/0006-291X(92)92277-5","volume":"189","author":"Pepper M.S.","year":"1992","unstructured":"Pepper MS, Ferrara N, Orci L. Biochem Biophys Res Commun, Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro.,, 1992, 189,, 824-831,","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=14","first-page":"508","volume":"69","author":"Goto F.","year":"1993","unstructured":"Goto F, Goto K, Weindel K. Lab Invest, Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.,, 1993, 69,, 508-517,","journal-title":"Lab Invest"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"II365","DOI":"10.1161\/01.CIR.92.9.365","volume":"92","author":"Asahara T.","year":"1995","unstructured":"Asahara T, Bauters C, Zheng LP. Circulation, Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.,, 1995, 92,, II365-II371,","journal-title":"Circulation"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.STR.0000157596.13234.95","volume":"36","author":"Wilson J.L.","year":"2005","unstructured":"Wilson JL, Hareendran A, Hendry A. Stroke, Reliability of the modified rankin scale across multiple raters: Benefits of a structured interview.,, 2005, 36,, 777-778,","journal-title":"Stroke"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jphys.2013.12.012","volume":"60","author":"Kwah L.K.","year":"2014","unstructured":"Kwah LK, Diogn J. J Physiother, National Institutes of Health Stroke Scale (NIHSS).,, 2014, 60,, 61-,","journal-title":"J Physiother"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1253\/circj.71.252","volume":"71","author":"Umetani K.","year":"2007","unstructured":"Umetani K, Kodama Y, Nakamura T. Circ J, High prevalence of paroxysmal atrial fibrillation and\/or atrial flutter in metabolic syndrome.,, 2007, 71,, 252-255,","journal-title":"Circ J"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1157\/13114954","volume":"61","author":"Ruiz Ortiz M.","year":"2008","unstructured":"Ruiz Ortiz M, Romo E, Mesa D. Rev Esp Cardiol, Predicting embolic events in patients with nonvalvular atrial fibrillation: Evaluation of the CHADS2 score in Mediterranean population.,, 2008, 61,, 29-35,","journal-title":"Rev Esp Cardiol"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","volume":"342","author":"Olesen J.B.","year":"2011","unstructured":"Olesen JB, Lip GY, Hansen ML. BMJ, Validation of risk stratification for predicting stroke and thromboembolism in atrial fibrillation nationwide cohort study.,, 2011, 342,, d124-,","journal-title":"BMJ"},{"key":"ref=21","author":"Rehm J.","unstructured":"Rehm J, Room R, Monteiro M, , World Health Organization Geneva,Alcohol use. In: , , Ezzati M, Lopez AD, Rodgers A, Murrhay ChJL, Eds., Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors. , 2004,959-1108","journal-title":"Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1253\/circj.71.252","volume":"71","author":"Umetani K.","year":"2007","unstructured":"Umetani K, Kodama Y, Nakamura T. Circ J, High prevalence of paroxysmal atrial fibrillation and\/or atrial flutter in metabolic syndrome.,, 2007, 71,, 252-255,","journal-title":"Circ J"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.20617","volume":"58","author":"Ay H.","year":"2005","unstructured":"Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. Ann Neurol, An evidence-based causative classification system for acute ischemic stroke.,, 2005, 58,, 688-697,","journal-title":"Ann Neurol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/STROKEAHA.107.489401","volume":"39","author":"Yip H.K.","year":"2008","unstructured":"Yip HK, Chang LT, Chang WN. Stroke, Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke.,, 2008, 39,, 69-74,","journal-title":"Stroke"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/cc10002","volume":"15","author":"Yip H.K.","year":"2011","unstructured":"Yip HK, Tsai TH, Lin HS. Crit Care, Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke.,, 2011, 15,, R40-,","journal-title":"Crit Care"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1124\/jpet.107.131532","volume":"325","author":"You D.","year":"2008","unstructured":"You D, Cochain C, Loinard C. J Pharmacol Exp Ther, Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.,, 2008, 325,, 766-773,","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/01.STR.0000149944.15406.16","volume":"36","author":"Ghani U.","year":"2005","unstructured":"Ghani U, Shuaib A, Salam A. Stroke, Endothelial progenitor cells during cerebrovascular disease.,, 2005, 36,, 151-153,","journal-title":"Stroke"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/hr.2009.16","volume":"32","author":"Zhou W.J.","year":"2009","unstructured":"Zhou WJ, Zhu DL, Yang GY. Hypertens Res, Circulating endothelial progenitor cells in chinese patients with acute stroke.,, 2009, 32,, 306-331,","journal-title":"Hypertens Res"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00415-006-0362-1","volume":"254","author":"Dunac A.","year":"2007","unstructured":"Dunac A, Frelin C, Popolo-Blondeau M, Chatel M, Mahagne MH, Philip PJ. J Neurol, Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization.,, 2007, 254,, 327-332,","journal-title":"J Neurol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jns.2012.12.005","volume":"325","author":"Paczkowska E.","year":"2013","unstructured":"Paczkowska E, Go\u0142\u0105b-Janowska M, Bajer-Czajkowska A. J Neurol Sci, Increased circulating endothelial progenitor cells in patients with haemorrhagic and ischaemic stroke: the role of Endothelin-1.,, 2013, 325,, 90-99,","journal-title":"J Neurol Sci"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"2827580","DOI":"10.1155\/2018\/2827580","volume":"2018","author":"Go\u0142\u0105b-Janowska M.","year":"2018","unstructured":"Go\u0142\u0105b-Janowska M, Paczkowska E, Machali\u0144ski B. Stem Cells Int, Effects of angiotensin-converting enzyme inhibition on circulating endothelial progenitor cells in patients with acute ischemic stroke.,, 2018, 2018,, 2827580-,","journal-title":"Stem Cells Int"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.LAB.0000050761.67879.E4","volume":"83","author":"Akita T.","year":"2003","unstructured":"Akita T, Murohara T, Ikeda H. Lab Invest, Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization.,, 2003, 83,, 65-73,","journal-title":"Lab Invest"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","volume":"7","author":"Carmeliet P.","year":"2001","unstructured":"Carmeliet P, Moons L, Luttun A. Nat Med, Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.,, 2001, 7,, 575-583,","journal-title":"Nat Med"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2005.09.043","volume":"393","author":"Guo H.","year":"2006","unstructured":"Guo H, Huang L, Cheng M, Jin X, Zhao Y, Yi M. Neurosci Lett, Serial measurement of serum basic fibroblast growth factor in patients with acute cerebral infarction.,, 2006, 393,, 56-59,","journal-title":"Neurosci Lett"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1093\/emboj\/18.14.3964","volume":"18","author":"Asahara T.","year":"1999","unstructured":"Asahara T, Takahashi T, Masuda H. EMBO J, VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.,, 1999, 18,, 3964-3972,","journal-title":"EMBO J"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.burns.2009.07.007","volume":"36","author":"Groger A.","year":"2010","unstructured":"Groger A, Piatkowski A, Grieb G, Wolter TP, Fuchs PC, Pallua N. Burns, The mobilisation of mononuclear cells and endothelial progenitor cells after burn injury in a porcine model.,, 2010, 36,, 545-551,","journal-title":"Burns"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4161\/cbt.9.9.11551","volume":"9","author":"Langenberg M.H.","year":"2010","unstructured":"Langenberg MH, Nijkamp MW, Roodhart JM. Cancer Biol Ther, Liver surgery induces an immediate mobilization of progenitor cells in liver cancer patients: a potential role for G-CSF.,, 2010, 9,, 743-748,","journal-title":"Cancer Biol Ther"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/01.STR.31.8.1863","volume":"31","author":"Slevin M.","year":"2000","unstructured":"Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Stroke, Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke.,, 2000, 31,, 1863-1870,","journal-title":"Stroke"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2377-13-32","volume":"13","author":"Matsuo R.","year":"2013","unstructured":"Matsuo R, Ago T, Kamouchi M. BMC Neurol, Clinical significance of plasma VEGF value in ischemic stroke-research for biomarkers in ischemic stroke (REBIOS) study.,, 2013, 13,, 32-,","journal-title":"BMC Neurol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1468-1331.2009.02731.x","volume":"17","author":"Lee S.C.","year":"2010","unstructured":"Lee SC, Lee KY, Kim YJ, Kim SH, Koh SH, Lee YJ. Eur J Neurol, Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis.,, 2010, 17,, 45-51,","journal-title":"Eur J Neurol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0006-8993(88)90370-8","volume":"460","author":"Finkelstein S.P.","year":"1988","unstructured":"Finkelstein SP, Apostolides PJ, Caday CG, Prosser J, Philips MF, Klagsbrun M. Brain Res, Increased basic fibroblast growth factor immunoreactivity at the site of focal brain wounds.,, 1988, 460,, 253-259,","journal-title":"Brain Res"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/STROKEAHA.108.529420","volume":"40","author":"Rafat N.","year":"2009","unstructured":"Rafat N, Beck GCh, Pe\u00f1a-Tapia PG, Schmiedek P, Vajkoczy P. Stroke, Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.,, 2009, 40,, 432-438,","journal-title":"Stroke"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/01.ATV.0000133488.56221.4a","volume":"24","author":"Choi J.H.","year":"2004","unstructured":"Choi JH, Kim KL, Huh W. Arterioscler Thromb Vasc Biol, Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure.,, 2004, 24,, 1246-1252,","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1161\/STROKEAHA.107.484386","volume":"38","author":"Sobrino T.","year":"2007","unstructured":"Sobrino T, Hurtado O, Moro MA. Stroke, The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome.,, 2007, 38,, 2759-2764,","journal-title":"Stroke"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jacc.2004.11.067","volume":"45","author":"Fadini G.P.","year":"2005","unstructured":"Fadini GP, Miorin M, Facco M. J Am Coll Cardiol, Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.,, 2005, 45,, 1449-1457,","journal-title":"J Am Coll Cardiol"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1172\/JCI200420622","volume":"114","author":"Taguchi A.","year":"2004","unstructured":"Taguchi A, Soma T, Tanaka H. J Clin Invest, Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model.,, 2004, 114,, 330-338,","journal-title":"J Clin Invest"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/hh0302.104460","volume":"90","author":"Zhang Z.G.","year":"2002","unstructured":"Zhang ZG, Zhang L, Jiang Q, Chopp M. Circ Res, Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse.,, 2002, 90,, 284-288,","journal-title":"Circ Res"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10557-008-6094-y","volume":"22","author":"Westenbrink B.D.","year":"2008","unstructured":"Westenbrink BD, Oeseburg H, Kleijn L. Cardiovasc Drugs Ther, Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.,, 2008, 22,, 265-274,","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2011.12.003","volume":"677","author":"Davidson E.P.","year":"2012","unstructured":"Davidson EP, Coppey LJ, Holmes A, Yorek MA. Eur J Pharmacol, Effect of inhibition of angiotensin converting enzyme and\/or neutral endopeptidase on vascular and neural complications in high fat fed\/low dose streptozotocin-diabetic rats.,, 2012, 677,, 180-187,","journal-title":"Eur J Pharmacol"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1373\/clinchem.2008.112334","volume":"55","author":"R\u00fcckerl R.","year":"2009","unstructured":"R\u00fcckerl R, Peters A, Khuseyinova N. Clin Chem, Determinants of the acute-phase protein C-reactive protein in myocardial infarction survivors: the role of comorbidities and environmental factors.,, 2009, 55,, 322-335,","journal-title":"Clin Chem"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/01.CIR.0000127577.63323.24","volume":"109","author":"Verma S.","year":"2004","unstructured":"Verma S, Kuliszewski MA, Li SH. Circulation, C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.,, 2004, 109,, 2058-2067,","journal-title":"Circulation"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1365-2362.2007.01876.x","volume":"37","author":"Turan R.G.","year":"2007","unstructured":"Turan RG, Brehm M, Koestering M. Eur J Clin Invest, Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.,, 2007, 37,, 842-851,","journal-title":"Eur J Clin Invest"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1160\/TH04-04-0261","volume":"92","author":"Guo M.","year":"2004","unstructured":"Guo M, Sahni SK, Sahni A, Francis CW. Thromb Haemost, Fibrinogen regulates the expression of inflammatory chemokines through NF-kappaB activation of endothelial cells.,, 2004, 92,, 858-866,","journal-title":"Thromb Haemost"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yexmp.2008.01.001","volume":"84","author":"Thacker R.I.","year":"2008","unstructured":"Thacker RI, Retzinger GS. Exp Mol Pathol, Adsorbed fibrinogen regulates the behavior of human dendritic cells in a CD18-dependent manner.,, 2008, 84,, 122-130,","journal-title":"Exp Mol Pathol"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0195-668X(02)00810-2","volume":"24","author":"Eidelman R.S.","year":"2003","unstructured":"Eidelman RS, Hennekens CH. Eur Heart J, Fibrinogen: A predictor of stroke and marker of atherosclerosis.,, 2003, 24,, 499-500,","journal-title":"Eur Heart J"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.clinbiochem.2010.09.023","volume":"43","author":"Mandraffino G.","year":"2010","unstructured":"Mandraffino G, Sardo MA, Riggio S. Clin Biochem, Smoke exposure and circulating progenitor cells: evidence for modulation of antioxidant enzymes and cell count.,, 2010, 43,, 1436-1442,","journal-title":"Clin Biochem"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"e0173030","DOI":"10.1371\/journal.pone.0173030","volume":"16","author":"Mandraffino G.","year":"2017","unstructured":"Mandraffino G, Aragona CO, Cairo V. PLoS One, Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects.,, 2017, 16,, e0173030-,","journal-title":"PLoS One"}],"container-title":["Current Neurovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T13:44:16Z","timestamp":1720964656000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169458\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,13]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567202616666190129164906","relation":{},"ISSN":["1567-2026"],"issn-type":[{"value":"1567-2026","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}